Postoperative outcomes after thyroidectomy: ERAS vs standard care

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults undergoing elective thyroidectomy are randomly assigned to an ERAS protocol or a local non-ERAS regimen. The trial will measure time to ambulation and length of hospital stay, with follow-up through four weeks to assess outcomes and any cost implications. Eligible patients will undergo standard preoperative assessments and consent, with randomization using a concealed sequence. Data on demographics, comorbidities, ASA status, and perioperative details will be collected. The study aims to determine if ERAS provides meaningful improvements in recovery and resource use.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patients aged 18-60 years.
2. Patients scheduled for elective subtotal, near-total, or total thyroidectomy.
3. Patients with ASA physical status I-III.
4. Patients with acceptable preoperative haematological, hepatic, and renal function and thyroid function adequately controlled for elective surgery.
5. Patients willing to complete the planned four-week follow-up.
6. Patients providing voluntary written informed consent for participation in the study.

Exclusion Criteria:

1. Patients undergoing thyroid lobectomy with or without isthmusectomy.
2. Patients undergoing emergency thyroid surgery.
3. Patients with ASA physical status greater than III.
4. Pregnant patients.
5. Patients with type I or type II diabetes mellitus.
6. Patients unwilling to participate in the study or withdrawing consent before random allocation.

Where it's running

• Allied Hospital Faisalabad
  Faisalabad, Punjab Province, Pakistan Recruiting

Study contacts

• Study coordinator: Tehreem H Doctor, MBBS
• Email: t.hannan95@gmail.com
• Phone: +923041696479

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• ETHY-001 safety and activity in Thyroid Eye Disease (TED)

  This study tests ETHY-001 versus placebo to see if it is safe, tolerable, and shows activity in people with thyroid eye disease.

  Recruiting at 2 sites Phase 1 Ethyreal Bio, Inc. · Orland Park, Illinois and 2 other locations · NCT07885605

• Role of LH and hCG in adults being evaluated for endocrine disorders

  This study looks at whether levels of luteinizing hormone (LH) and hCG in adults undergoing endocrine evaluation relate to their disease presence and outcomes.

  Recruiting Copenhagen University Hospital at Herlev · Herlev · NCT07824102

• WeChat-supported neck exercises after thyroidectomy

  A telehealth program using a WeChat mini program tests if guided neck exercises after thyroid surgery help early recovery and quality of life.

  Recruiting Shanghai 6th People's Hospital · Shanghai, Shanghai Municipality · NCT07707401

• NIRAF-guided identification of parathyroids during thyroidectomy

  A wearable near-infrared autofluorescence device is being tested to help surgeons find and protect the parathyroid glands during thyroid surgery in adults.

  Recruiting Ss. Cyril and Methodius University of Skopje · Skopje · NCT07617584

• Dexmedetomidine to improve waking and reduce coughing after thyroid surgery

  This will test whether giving dexmedetomidine from before anesthesia and continuing it during thyroid surgery reduces coughing, agitation, and the amount of anesthetic or opioid needed when waking up.

  Recruiting Phase 4 Bach Mai Hospital · Hanoi · NCT07462195

• Cold (non-thermal) plasma to improve healing and reduce complications after thyroid removal

  This will test whether applying helium-based non-thermal (cold) plasma during total thyroidectomy helps wounds heal faster and reduces pain, inflammation, and infections in adults having their thyroid removed.

  Recruiting National Institute of Nuclear Research - Mexico · Ocoyoacac, State of Mexico · NCT07382973

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.